We are live on
!
Find out more
Bailard Portfolio holdings
AUM
$4.94B
Turnover
24.33%
1-Year Est. Return
25.15%
This Fund
S&P 500
This Quarter
Est. Return
-1.1%
1 Year Est. Return
+25.15%
3 Year Est. Return
+104.94%
5 Year Est. Return
+121.63%
10 Year Est. Return
+438.61%
AUM
$4.35B
AUM Growth
-$166M
(-3.7%)
Cap. Flow
-$40.7M
Cap. Flow
% of AUM
-0.94%
Top 10 Holdings %
Top 10 Hldgs %
29.99%
Holding
855
New
111
Increased
222
Reduced
267
Closed
119
Avg Time Held
3.8
years
Top 10 Avg Time Held
2.9
years
Top 20 Avg Time Held
3.9
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR Bloomberg 1-3 Month T-Bill ETF
BIL
|
+$87.1M |
| 2 |
iShares iBonds Dec 2028 Term Treasury ETF
IBTI
|
+$30.4M |
| 3 |
JPMorgan Ultra-Short Municipal Income ETF
JMST
|
+$14.8M |
| 4 |
iShares US Treasury Bond ETF
GOVT
|
+$10.9M |
| 5 |
ServiceNow
NOW
|
+$8.25M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$92.5M |
| 2 |
iShares iBonds Dec 2026 Term Treasury ETF
IBTG
|
+$27.9M |
| 3 |
Vanguard Short-Term Inflation-Protected Securities Index Fund
VTIP
|
+$26.6M |
| 4 |
iShares California Muni Bond ETF
CMF
|
+$11.8M |
| 5 |
SPDR Gold Trust
GLD
|
+$7.02M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 42.14% |
| 2 | Technology | 20.66% |
| 3 | Financials | 7.46% |
| 4 | Healthcare | 7.26% |
| 5 | Communication Services | 6% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
701
Haleon
HLN
$44.5B
| $210K | ﹤0.01% |
20,979
-280
| -1% | -$2.91K |
2025 Q1
4 quarters
|
|
702
Ameren
AEE
$29.4B
| $209K | ﹤0.01% |
+1,903
| New | +$203K |
2026 Q1
0 quarters
|
|
703
KB Home
KBH
$2.62B
| $207K | ﹤0.01% |
+4,000
| New | +$235K |
2026 Q1
0 quarters
|
|
704
Sturm, Ruger & Co
RGR
$690M
| $204K | ﹤0.01% |
+5,100
| New | +$194K |
2026 Q1
0 quarters
|
|
705
Sun Communities
SUI
$14.3B
| $202K | ﹤0.01% |
+1,600
| New | +$207K |
2026 Q1
0 quarters
|
|
706
Toll Brothers
TOL
$12.3B
| $200K | ﹤0.01% |
+1,466
| New | +$215K |
2026 Q1
0 quarters
|
|
707
Escalade
ESCA
$254M
| $196K | ﹤0.01% |
+11,430
| New | +$173K |
2026 Q1
0 quarters
|
|
708
Perma-Fix Environmental Services
PESI
$260M
| $190K | ﹤0.01% |
17,800
| – | – |
2023 Q4
9 quarters
|
|
709
Greenlight Captial
GLRE
$480M
| $180K | ﹤0.01% |
+10,400
| New | +$151K |
2026 Q1
0 quarters
|
|
710
Talos Energy
TALO
$2.94B
| $161K | ﹤0.01% |
+10,200
| New | +$131K |
2026 Q1
0 quarters
|
|
711
Lifetime Brands
LCUT
$187M
| $155K | ﹤0.01% |
+27,089
| New | +$103K |
2026 Q1
0 quarters
|
|
712
Zevra Therapeutics
ZVRA
$590M
| $137K | ﹤0.01% |
14,700
+1,800
| +14% | +$16.2K |
2025 Q4
1 quarter
|
|
713
Grocery Outlet
GO
$1.28B
| $136K | ﹤0.01% |
19,289
| – | – |
2022 Q4
13 quarters
|
|
714
Nkarta
NKTX
$128M
| $134K | ﹤0.01% |
63,400
| – | – |
2025 Q3
2 quarters
|
|
715
Artiva Biotherapeutics
ARTV
$286M
| $133K | ﹤0.01% |
+20,700
| New | +$102K |
2026 Q1
0 quarters
|
|
716
Zedge
ZDGE
$42.5M
| $131K | ﹤0.01% |
44,785
-15,315
| -25% | -$49.5K |
2025 Q2
3 quarters
|
|
717
Corbus Pharmaceuticals
CRBP
$88.4M
| $127K | ﹤0.01% |
+13,500
| New | +$114K |
2026 Q1
0 quarters
|
|
718
DELISTED
Simulations Plus
SLP
| $118K | ﹤0.01% |
+10,000
| New | +$147K |
2026 Q1
0 quarters
|
|
719
Vanda Pharmaceuticals
VNDA
$242M
| $116K | ﹤0.01% |
+16,800
| New | +$130K |
2026 Q1
0 quarters
|
|
720
Nuvation Bio
NUVB
$1.57B
| $116K | ﹤0.01% |
+27,000
| New | +$150K |
2026 Q1
0 quarters
|
|
721
Puma Biotechnology
PBYI
$509M
| $116K | ﹤0.01% |
+18,100
| New | +$117K |
2026 Q1
0 quarters
|
|
722
Emergent Biosolutions
EBS
$330M
| $113K | ﹤0.01% |
+13,600
| New | +$141K |
2026 Q1
0 quarters
|
|
723
Oramed Pharmaceuticals
ORMP
$168M
| $110K | ﹤0.01% |
+32,478
| New | +$110K |
2026 Q1
0 quarters
|
|
724
Black Diamond Therapeutics
BDTX
$98.2M
| $110K | ﹤0.01% |
+51,500
| New | +$122K |
2026 Q1
0 quarters
|
|
725
Whitehawk Therapeutics
WHWK
$165M
| $108K | ﹤0.01% |
+31,398
| New | +$98.3K |
2026 Q1
0 quarters
|
|
Similar funds
SL
FC
Bailard's Q1 2026 Portfolio in Review
As of Q1 2026, Bailard held 855 positions worth $4.35B, down 3.7% from $4.52B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Bailard's Q1 2026 filing shows 111 new, 222 increased, 267 reduced and 119 closed positions. Its largest new stake was iShares iBonds Dec 2028 Term Treasury ETF: 1,361,953 shares worth $30.3M. The largest sale was Invesco QQQ Trust, an estimated $92.5M.
By sector, the portfolio is most concentrated in Miscellaneous at 42% of assets, up from 42% a quarter earlier, followed by Technology and Financials.
- Bailard's largest Q1 2026 buy was iShares iBonds Dec 2028 Term Treasury ETF: 1,361,953 shares worth $30.3M.
- Bailard added most to State Street SPDR Bloomberg 1-3 Month T-Bill ETF in Q1 2026, an estimated $87.1M increase.
- Bailard's biggest Q1 2026 reduction was Invesco QQQ Trust, cutting an estimated $92.5M.
- Bailard fully exited Vanguard Short-Term Inflation-Protected Securities Index Fund in Q1 2026, selling an estimated $26.6M.
- Bailard's ten largest holdings make up 30% of its $4.35B portfolio in Q1 2026.
- Bailard opened 111 new positions and closed 119 in Q1 2026.
- Bailard's portfolio value fell 3.7% quarter-over-quarter to $4.35B.
Based on Bailard's 13F filing for Q1 2026, filed 11 May 2026.